Data last refreshed 16 days ago — analysis may not reflect the latest market data

EXCEXC

US

NEUTRAL

$46.53

P/E

17.04

PEG

12.17

FCF Yield

Rev Growth YoY

+4.6% YoY

Gross Margin

40.4%

Health Score

4/10

D/E Ratio

1.74

Confidence

LOW


Advertisement

Business Snapshot

The company, trading under EXC, operates in a sector that is not specified in the data. The lack of market capitalisation and TTM revenue figures prevents a definitive assessment of its financial scale. With no quarterly financial data available, the company's operational trends and competitive position remain unclear based on the provided information. The data shows the company has beat earnings estimates in all four of the most recent quarters, suggesting a history of reliable financial reporting. Overall, the absence of key business identifiers makes it difficult to characterise the company's market standing or defining characteristics.

Advertisement

Financial Health

The company reports a gross margin of 40.4% and a net margin of 11.2%, though the data does not include prior-year comparatives to assess trend direction. The balance sheet shows a debt/equity ratio of 1.74x, which is elevated, combined with a current ratio of 0.92x, indicating that the company has less in short-term assets than liabilities due and may face liquidity pressure...

Risk Assessment

  • DEBT / LIQUIDITY — Debt/equity of 1.74x is elevated, while the current ratio of 0.92x is below 1.0x, indicating strained short-term liquidity.
  • VALUATION — The PEG ratio of 12.17x signals expensive growth-adjusted valuation despite a P/E (17.04x) below the sector average of 22x.
  • TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
  • EARNINGS QUALITY — The company beat estimates in all 4 of the last 4 quarters, which is a positive signal and does not represent a credibility risk.
  • FCF / CASH BURN — Free cash flow is unavailable, preventing an assessment of cash generation or burn....

The company reports a gross margin of 40.4% and a net margin of 11.2%, though the data does not include prior-year comparatives to assess trend direction. The balance sheet shows a debt/equity ratio of 1.74x, which is elevated, combined with a current ratio of 0.92x, indicating that the company has less in short-term assets than liabilities due and may face liquidity pressure. Return on equity stands at 9.8%, suggesting a modest ability to generate profit from shareholder equity. Free cash flow is not available in the data payload, making it impossible to assess cash generation or the sustainability of operations. Overall financial health is constrained by significant debt and a weak liquidity position, which could limit dividend capacity and raise the risk of dilution.

- DEBT / LIQUIDITY — Debt/equity of 1.74x is elevated, while the current ratio of 0.92x is below 1.0x, indicating strained short-term liquidity. - VALUATION — The PEG ratio of 12.17x signals expensive growth-adjusted valuation despite a P/E (17.04x) below the sector average of 22x. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - EARNINGS QUALITY — The company beat estimates in all 4 of the last 4 quarters, which is a positive signal and does not represent a credibility risk. - FCF / CASH BURN — Free cash flow is unavailable, preventing an assessment of cash generation or burn.

Unlock the full AI report

Full 8-section analysis includes:

Financial Health
Growth Momentum
Valuation Snapshot
Risk Flags
Sentiment & News
Technical Snapshot
Full Verdict with Confidence Rating
Last updated 401 hours ago · Data sourced from FMP & Finnhub · Not financial advice